Epigenetic clocks powerfully predict biological age independent of chronological age. These clocks reflect altered gene and protein expression patterns, particularly those resulting from differential DNA methylation (DNAm) at CpG (5′-C-phosphate-G-3′) sites. DNAm that accumulates over time is a testament to the toll social, behavioral, and environmental forces can have on the body.
1-3 These alterations often result in pathogenic processes (eg, genomic instability, systemic inflammation, and oxidative stress) characteristic of aging and chronic disease.
1,4,5 As such, myriad clocks reflecting epigenetic age have been developed for a range of age- or disease-related targets.
4,6 The GrimAge series contains second-generation markers of epigenetic aging that account for clinical and functional biomarkers, and is most notable for its robust associations with human mortality and morbidity risk, including time to death and comorbidity counts.
6,7 The recently developed version 2 of the GrimAge clock (hereafter, GrimAge2) improved on the first’s predictive abilities and confirmed its applicability for people at midlife and of different racial and ethnic backgrounds.
1,6